OCS

argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting

Retrieved on: 
Thursday, March 7, 2024

“We are opening a new chapter for the VYVGART portfolio,” said Luc Truyen, M.D., Ph.D., Chief Medical Officer at argenx.

Key Points: 
  • “We are opening a new chapter for the VYVGART portfolio,” said Luc Truyen, M.D., Ph.D., Chief Medical Officer at argenx.
  • These positive data from the ADHERE study have been submitted to the FDA for potential approval of VYVGART Hytrulo in CIDP with a PDUFA target action date of June 21, 2024.
  • Achievement of MSE enables significant quality of life improvements: ADAPT/ADAPT+ demonstrate that >40% of patients achieve minimal symptom expression (MSE) across both studies.
  • Patients achieving MSE experience quality of life outcomes comparable to healthy populations, suggesting MSE could be a primary goal of gMG treatment.

Oculis Provides Updates at R&D Day on Late-Stage Clinical Trials and Announces Key Leadership Appointments

Retrieved on: 
Wednesday, February 28, 2024

In-person and virtual R&D Day today from 9:00 AM to 11:00 AM EST at the InterContinental New York Barclay.

Key Points: 
  • In-person and virtual R&D Day today from 9:00 AM to 11:00 AM EST at the InterContinental New York Barclay.
  • “2024 promises to be another exciting year for Oculis as we advance our late-stage clinical development programs.
  • I am certain that the extensive experience each of them brings will be invaluable to Oculis,” said Riad Sherif, M.D., Chief Executive Officer of Oculis.
  • Oculis also announced today key executive appointments to bolster its leadership and scientific advisory teams.

Community Savings Credit Union announces affordable invoice factoring for cannabis licensed producers in BC

Retrieved on: 
Friday, February 23, 2024

VANCOUVER, BC / Unceded Territories of the Musqueam, Squamish and Tsleil-Waututh Nations, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Community Savings , a BC-based credit union, working exclusively with We Can Capital Inc. , has introduced an innovative invoice factoring program crafted for British Columbia’s licensed cannabis producers (LPs).

Key Points: 
  • VANCOUVER, BC / Unceded Territories of the Musqueam, Squamish and Tsleil-Waututh Nations, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Community Savings , a BC-based credit union, working exclusively with We Can Capital Inc. , has introduced an innovative invoice factoring program crafted for British Columbia’s licensed cannabis producers (LPs).
  • This affordable invoice factoring program enables BC LPs to receive the funds from their BC and Ontario government invoices early.
  • Community Savings with We Can Capital is dedicated to facilitating the sustainable growth of the BC cannabis industry.
  • Mike Schilling, President and CEO of Community Savings Credit Union, said: “As a pro-cannabis credit union, we are proud to be the only industry-owned solution to give BC LPs affordable access to working capital from their provincial receivables.

Enrollment Opens for Vineyard Wind 1 Fisheries Compensation Program

Retrieved on: 
Monday, March 4, 2024

The launch of the program opens a 90-day window for fishermen to qualify for compensation at www.vw1fisheriescomp.com .

Key Points: 
  • The launch of the program opens a 90-day window for fishermen to qualify for compensation at www.vw1fisheriescomp.com .
  • The Vineyard Wind Fisheries Compensation Fund will bolster our commercial fisheries during this time of transition to clean energy—we hope this fund can be a model for ensuring offshore wind and commercial fisheries thrive together."
  • To support the program, Vineyard Wind 1 has established three escrow funds to compensate affected fishermen in Massachusetts, Rhode Island, Connecticut, New Jersey, and New York.
  • Fishermen will not need to demonstrate economic impacts from Vineyard Wind 1 to qualify for the program or receive compensation payments.

MANDARA Phase III data published in New England Journal of Medicine show remission is an achievable goal in eosinophilic granulomatosis with polyangiitis (EGPA) with FASENRA

Retrieved on: 
Friday, February 23, 2024

AstraZeneca is an established leader in respiratory care with a 50-year heritage and a growing portfolio of medicines in immune-mediated diseases.

Key Points: 
  • AstraZeneca is an established leader in respiratory care with a 50-year heritage and a growing portfolio of medicines in immune-mediated diseases.
  • Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA).
  • Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
  • A Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES) (NATRON).

Hollysys Automation Technologies Reports Unaudited Financial Results for the Second Quarter and the First Half Year Ended December 31, 2023

Retrieved on: 
Thursday, March 7, 2024

BEIJING, March 7, 2024 /PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys," the "Company" or "we"), a leading provider of automation and control technologies and applications in China, today announced its unaudited financial results for the second quarter and the first half of fiscal year 2024 ended December 31, 2023.

Key Points: 
  • Net income attributable to Hollysys was $45.8 million, a decrease of 34.3% compared to the comparable prior year period.
  • Non-GAAP net income attributable to Hollysys was $46.8 million, a decrease of 35.5% compared to the comparable prior year period.
  • BEIJING, March 7, 2024 /PRNewswire/ -- Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) ("Hollysys," the "Company" or "we"), a leading provider of automation and control technologies and applications in China, today announced its unaudited financial results for the second quarter and the first half of fiscal year 2024 ended December 31, 2023.
  • Second Quarter and First Half Year Ended December 31, 2023 Unaudited Financial Results Summary

Prescription of Oral Contraceptives by Licensed Pharmacists in the US

Retrieved on: 
Monday, March 4, 2024

ASHBURN, Va., March 4, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Prescription of Oral Contraceptives by Licensed Pharmacists in the US" .

Key Points: 
  • ASHBURN, Va., March 4, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Prescription of Oral Contraceptives by Licensed Pharmacists in the US" .
  • Oral contraceptives (OCs) provide a highly effective method of contraception if adherence is maintained; OCs have been prescribed in the US and globally for several decades.
  • The American College of Clinical Pharmacology (ACCP) strongly recommends the enactment of an initiative that permits licensed US pharmacists to prescribe OCs on a national basis.
  • This supports OCs as suitable for prescription by licensed pharmacists at a national level.

CannMart to Expand Roilty Product Portfolio to Include Craft and Solventless Offerings

Retrieved on: 
Friday, February 9, 2024

Live resin reserve represents a premium and exclusive concentrate made in small batches, boasting only fresh frozen cannabis flower from small craft and micro-growers in Quebec.

Key Points: 
  • Live resin reserve represents a premium and exclusive concentrate made in small batches, boasting only fresh frozen cannabis flower from small craft and micro-growers in Quebec.
  • Roilty’s first mechanical and solventless concentrate comes in the form of black hash and it joins a small number of leading brands that offer solventless products.
  • Both live resin reserve and solventless concentrates represent a significant accomplishment for Roilty, underscoring CannMart’s commitment to innovation while seeking out value propositions in the concentrate category.
  • “This commitment has been the driving force in the evolving product pipeline with Roilty, allowing us to manage the portfolio effectively and adapt as tastes of the market shifts.

Vista Physical Therapy Opens New Outpatient Clinic in Denton

Retrieved on: 
Wednesday, February 7, 2024

Frisco, Texas, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vista Physical Therapy , a partner of Physical Rehabilitation Network (PRN) , has announced the grand opening of its third outpatient clinic in Denton, in collaboration with its joint venture partnership with Medical City Healthcare .

Key Points: 
  • Frisco, Texas, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Vista Physical Therapy , a partner of Physical Rehabilitation Network (PRN) , has announced the grand opening of its third outpatient clinic in Denton, in collaboration with its joint venture partnership with Medical City Healthcare .
  • The Vista-Denton clinic offers comprehensive physical therapy services to patients of all ages, encompassing a diverse range of specialties.
  • Vista Physical Therapy’s Denton clinic proudly accepts most insurance plans and will work with patients to help them better understand the benefits of physical therapy and what will be covered by their insurance.
  • To schedule an appointment at the new Denton clinic, please visit the Vista Physical Therapy website .

Radicle Femmes Celebrates Women in Cannabis in Toronto, Ontario

Retrieved on: 
Thursday, February 1, 2024

Toronto, ON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Marigold PR , an award-winning public relations agency to the North American cannabis industry, presents the inaugural Radicle Femmes , Canada’s largest networking event celebrating women in cannabis.

Key Points: 
  • Toronto, ON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Marigold PR , an award-winning public relations agency to the North American cannabis industry, presents the inaugural Radicle Femmes , Canada’s largest networking event celebrating women in cannabis.
  • We’re proud to sponsor Radicle Femmes, which celebrates the many contributions of women who continue pushing the legal cannabis industry forward.”
    Women in Leadership will provide valuable insights and inspiration from accomplished women in leadership roles within the cannabis industry.
  • Radicle Femmes was created to pave the way for a more inclusive and prosperous future for women in cannabis.
  • Radicle Femmes invites potential partners to join in celebrating and promoting women in cannabis.